KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Return on Invested Capital (2024 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Return on Invested Capital for 2 consecutive years, with 0.14% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Invested Capital changed N/A year-over-year to 0.14%, compared with a TTM value of 0.14% through Jun 2025, changed N/A, and an annual FY2025 reading of 1.14%, down 115.0% over the prior year.
  • Return on Invested Capital was 0.14% for Q2 2025 at Biocryst Pharmaceuticals, down from 0.08% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.01% in Q4 2024 and bottomed at 0.14% in Q2 2025.